Medical Device News

Inscopix Expands Strategic Partnership with GRINTECH to Become Exclusive Global Supplier of GRIN lenses

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is expanding its strategic supplier partnership with leading gradient index (GRIN) lens manufacturer GRINTECH GmbH to be the sole exclusive seller of GRIN lenses for neuroscience research applications.

The company offers innovative miniature-microscope (miniscope) based imaging platforms and scientific consulting services for advancing neuroscience research, and with this partnership, hopes to bring to the broader scientific community the innovative GRIN-based lens technology that GRINTECH has pioneered.

In addiiton, the company has committed to continuing to support legacy GRINTECH customers with their micro-endoscope imaging needs across all non-human neuroscience research applications, and with this new agreement, Inscopix will serve any customer in the brain imaging research market. The partnership will also mean that Inscopix Field Scientific Consultants, Customer Support teams and the on-line support portal Inscopix iQ will now be available to all GRIN lens customers, irrespective of whether the user or lab is a customer of Inscopix’s miniscope-based platform.

“As a dedicated neuroscience partner, we are excited to be able to serve the broader research community with not just more GRIN lens products, but with our enhanced scientific support, customer service and volume-based pricing discounts,” said Kunal Ghosh, Ph.D., CEO of Inscopix. ”The expansion of our partnership with GRINTECH also represents a natural evolution of the long-standing relationship our two companies have had.”

Inscopix’s technology is already in use by basic and translational researchers in more than 600 labs in both academia and pharma, which have produced almost 200 publications describing many breakthrough discoveries about brain function and disorders. By uncovering the connections between neurons, the company and its collaborators are able to gain insights into directly actionable targets for therapeutic intervention to treat brain-related diseases.

“This partnership allows our customers to get a higher quality product with support and resources built in, and we’re looking forward to this improved buyer experience,” said Bernhard Messerschmidt, Ph.D., CEO of GRINTECH GmbH.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.